ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,491 | -84.7% | 31,745 | -35.8% | 0.00% | -100.0% |
| Q1 2023 | $284,746 | -56.2% | 49,435 | +11.0% | 0.00% | -50.0% |
| Q2 2022 | $650,000 | +5316.7% | 44,523 | +7320.5% | 0.00% | – |
| Q1 2022 | $12,000 | -97.7% | 600 | -98.0% | 0.00% | -100.0% |
| Q4 2021 | $518,000 | +524.1% | 29,641 | +179.1% | 0.01% | +400.0% |
| Q3 2021 | $83,000 | -35.7% | 10,622 | -15.1% | 0.00% | 0.0% |
| Q2 2021 | $129,000 | – | 12,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |